| pubmed-article:15726289 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15726289 | lifeskim:mentions | umls-concept:C0600148 | lld:lifeskim |
| pubmed-article:15726289 | lifeskim:mentions | umls-concept:C0449416 | lld:lifeskim |
| pubmed-article:15726289 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
| pubmed-article:15726289 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:15726289 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:15726289 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:15726289 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15726289 | pubmed:dateCreated | 2005-2-23 | lld:pubmed |
| pubmed-article:15726289 | pubmed:abstractText | A set of 600 actinomycetes strains which were isolated from marine sediments from various sites in the Pacific and Atlantic Oceans were screened for the production of bioactive secondary metabolites. Marine streptomycete strains were found to be producers of well known chemically diverse antibiotics isolated from terrestrial streptomycetes, as in the case of marine Micromonospora strains. New marine members of the rare genus Verrucosispora seem to be a promising source for novel bioactive secondary metabolites as shown in the case of the abyssomicin producing strain AB-18-032. | lld:pubmed |
| pubmed-article:15726289 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15726289 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15726289 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15726289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15726289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15726289 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15726289 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15726289 | pubmed:issn | 0003-6072 | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:WardAlan CAC | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:GoodfellowMic... | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:BullAlan TAT | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:FiedlerHans-P... | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:MihmGerhardG | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:PotteratOlivi... | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:PuderCarstenC | lld:pubmed |
| pubmed-article:15726289 | pubmed:author | pubmed-author:BruntnerChris... | lld:pubmed |
| pubmed-article:15726289 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15726289 | pubmed:volume | 87 | lld:pubmed |
| pubmed-article:15726289 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15726289 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15726289 | pubmed:pagination | 37-42 | lld:pubmed |
| pubmed-article:15726289 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:meshHeading | pubmed-meshheading:15726289... | lld:pubmed |
| pubmed-article:15726289 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15726289 | pubmed:articleTitle | Marine actinomycetes as a source of novel secondary metabolites. | lld:pubmed |
| pubmed-article:15726289 | pubmed:affiliation | Mikrobiologisches Institut, Universität Tübingen, Auf der Morgenstelle 28, D-72076 Tübingen, Germany. hans-peter.fiedler@uni-tuebingen.de | lld:pubmed |
| pubmed-article:15726289 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15726289 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15726289 | lld:pubmed |
